Concepedia

Katherine Davy

KD

8

Publications

587

Citations

8

H-Index

2004

Active since

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

GlaxoSmithKline (United States)

HealthPartners

Medisch Spectrum Twente

Levine Cancer Institute

Katherine Davy is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, immunology, and rheumatology.

Top concepts

Publications per year

2004–2022

8

Publications

8

A Multicenter, Randomized, Double-blind, Placebo-Controlled Trial ofParoxetine in Children and Adolescents With Social Anxiety Disorder

Karen Dineen Wagner, R.M.F. Berard, Murray B. Stein et al. · Archives of General Psychiatry · 2004 · 243 citations

Lamotrigine as Add-On Therapy in Schizophrenia

Donald Goff, Richard S.E. Keefe, Leslie Citrome et al. · Journal of Clinical Psychopharmacology · 2007 · 121 citations

Controlled-Release Paroxetine in the Treatment of Patients With Social Anxiety Disorder

Ulla Lepola, Bettina Bergtholdt, Jane St Lambert et al. · The Journal of Clinical Psychiatry · 2004 · 66 citations

A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR)

Jatin Patel, Damon Bass, Albertus Beishuizen et al. · European Respiratory Journal · 2022 · 42 citations · Full text

Efficacy, patient-reported outcomes, and safety of the anti-granulocyte macrophage colony-stimulating factor antibody otilimab (GSK3196165) in patients with rheumatoid arthritis: a randomised, phase 2b, dose-ranging study

Christopher D. Buckley, Jesus Abraham Simón Campos, Brandon Becker et al. · The Lancet Rheumatology · 2020 · 41 citations · Full text

, , +11

Rows per page

1–5 of 8